ESTA
Establishment Labs Holdings Inc.NASDAQHealthcare$58.31-0.66%ClosedMarket Cap: $1.71B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
73.35
P/S
8.10
EV/EBITDA
-75.29
DCF Value
$-86.43
FCF Yield
-3.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
69.3%
Operating Margin
-18.5%
Net Margin
-24.2%
ROE
-201.8%
ROA
-14.8%
ROIC
-11.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $64.6M | 70.5% | $-3.9M | $-2.6M | $-0.09 | — |
| FY 2025 | $211.1M | 69.3% | $-39.0M | $-51.1M | $-1.72 | — |
| Q3 2025 | $53.8M | 70.1% | $-4.0M | $-11.1M | $-0.38 | — |
| Q2 2025 | $51.3M | 68.8% | $-14.1M | $-16.6M | $-0.56 | — |
| Q1 2025 | $41.4M | 67.2% | $-16.9M | $-20.7M | $-0.70 | — |
| Q4 2024 | $44.5M | 68.5% | $-18.7M | $-34.5M | $-1.19 | — |
| FY 2024 | $166.0M | 66.0% | $-50.0M | $-84.6M | $-3.00 | — |
| Q3 2024 | $40.2M | 63.9% | $-13.1M | $-16.7M | $-0.60 | — |
| Q2 2024 | $44.1M | 65.6% | $-9.3M | $-17.2M | $-0.62 | — |
| Q1 2024 | $37.2M | 65.6% | $-8.8M | $-16.2M | $-0.58 | — |
| Q4 2023 | $31.6M | 65.2% | $-22.1M | $-20.5M | $-0.79 | — |
| FY 2023 | $165.2M | 64.8% | $-65.0M | $-78.5M | $-3.07 | — |